title: Eruptive squamous cell carcinoma in a patient receiving abatacept for rheumatoid arthritis.
authors.affiliation: University of Washington School of Medicine, Seattle, Washington.
authors.forename: Maria A
authors.initials: MA
authors.lastname: Corcorran
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Olson
authors.forename: Corinne
authors.initials: C
authors.lastname: Hecht
authors.forename: Stevan
authors.initials: S
authors.lastname: Knezevich
authors.forename: Jay C
authors.initials: JC
authors.lastname: Vary
mesh_terms: D000069594:Abatacept; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D001707:Biopsy, Needle; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D018796:Immunoconjugates / Q000009:adverse effects* / Q000627:therapeutic use; D007150:Immunohistochemistry; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007275:Injections, Intravenous; D055623:Keratosis, Actinic / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery; D008875:Middle Aged; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery
chemical_list: D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept